Skip to main content
. 2018 Jan 12;58(3):981–987. doi: 10.1007/s00394-018-1612-6

Table 1.

Brachial diameter, brachial artery FMD, RHI, PWVcf, PWVcr, cAIx, cAIx75, pAIx, CRAE, CRVE, AVR, pSBP, pDBP, cSBP, cDBP and HR in fasting (T0) and postprandial (T150) condition after 4 weeks of placebo or theobromine consumption

Placebo Theobromine
T0 T150 Change T0 T150 Change
Brachial diameter (cm) 0.49 ± 0.06 0.50 ± 0.08 0.00 ± 0.04 0.49 ± 0.07 0.52 ± 0.08 0.03 ± 0.04*
Brachial artery FMD (%)$ 4.87 ± 2.54 3.87 ± 2.32 − 1.00 ± 2.97 4.43 ± 2.01 3.65 ± 2.25 − 0.78 ± 2.48
RHI1,$ 2.64 ± 0.68 2.38 ± 0.61 − 0.24 ± 0.65 2.58 ± 0.61 2.23 ± 0.47 − 0.35 ± 0.60
PWVcr (m/s) 7.1 ± 1.1 7.1 ± 1.1 − 0.1 ± 1.2 7.4 ± 1.3 7.1 ± 1.5 − 0.3 ± 1.6
PWVcf (m/s) 9.0 ± 1.4 9.0 ± 1.6 0.0 ± 1.3 8.8 ± 1.6 9.0 ± 1.5 0.2 ± 1.5
cAIx (%) 28.3 ± 9.9 21.9 ± 10.5 − 6.4 ± 6.2 26.6 ± 10.4# 15.2 ± 11.2 − 11.3 ± 8.4
pAIx (%) − 14.8 ± 14.9 − 24.1 ± 13.7 − 9.3 ± 10.6 − 16.8 ± 15.3 − 32.4 ± 13.8 − 15.6 ± 14.4*
cAIx75 (%) 21.6 ± 8.7 16.3 ± 9.6 − 5.3 ± 6.5 21.4 ± 9.3 11.2 ± 10.7 − 10.3 ± 8.2*
CRAE (µm)3 135 ± 19 135 ± 19 0 ± 9 134 ± 19 136 ± 19 2 ± 6
CRVE (µm)3 230 ± 14 231 ± 13 0 ± 5 228 ± 14 231 ± 13 2 ± 7
AVR3 0.59 ± 0.09 0.59 ± 0.09 0.00 ± 0.05 0.58 ± 0.09 0.59 ± 0.09 0.01 ± 0.04
pSBP (mmHg)$ 134 ± 14 132 ± 12 − 3 ± 9 134 ± 14 130 ± 13 − 4 ± 10
pDBP (mmHg)$ 85 ± 10 83 ± 8 − 2 ± 5 86 ± 10 83 ± 9 − 3 ± 6
cSBP (mmHg)$ 126 ± 13 121 ± 11 − 5 ± 8 125 ± 12 118 ± 13 − 7 ± 10
cDBP (mmHg)$ 86 ± 9 84 ± 9 − 2 ± 6 87 ± 9 84 ± 9 − 3 ± 5
HR (bpm)$ 62 ± 9 64 ± 10 2 ± 4 62 ± 8 65 ± 10 3 ± 7

Values are mean ± SD. n = 44. Linear mixed models were conducted to find significant differences

FMD flow mediated dilation, RHI reactive hyperemia index, PWV pulse wave velocity, PWVcf PWV of the carotis-femoralis, PWVcr PWV of the carotis-radialis, cAIx central augmentation index, cAIx75 cAIx corrected for a heart rate of 75, pAIx peripheral augmentation index, CRAE mean arteriolar width, CRVE mean venular width, AVR arteriolar to venular ratio, p peripheral, c central, SBP systolic blood pressure, DBP diastolic blood pressure, HR heart rate

#P < 0.05 for fasting differences from placebo

* P < 0.05 for treatment × meal effects

$P < 0.05 for meal effects

1n = 42 at T0, n = 41 at T150 due to missing values

2n = 41 at T0, n = 39 at T150 due to missing values